FIRST SUCCESSFUL CLINICAL TRIAL TO PROTECT THE BRAIN FROM DAMAGE CAUSED BY STROKE

摘要

A team of Canadian scientists and clinicians, led by Dr. Michael Hill of the Calgary Stroke Program at Foothills Medical Centre and University of Calgary's Hotchkiss Brain Institute (HBI), have demonstrated that a neuro-protectant drug, developed at the Krembil Neurosci-ence Centre, located at the Toronto Western Hospital, protects the human brain against the damaging effects of stroke. The study, "Safety and efficacy of NA-1 for neuroprotection in iatrogenic stroke after endovascular aneurysm repair: a randomized controlled trial," published in The Lancet Neurology, was conducted concurrently with a laboratory study published in Science Translational Medicine, that predicted the benefits of the stroke drug.